Navicixizumab ELISA Kit
Product Specifications
Background
Navicixizumab is an anti-DLL4/VEGF bispecific antibody that has demonstrated robust in vivo antitumor efficacy in a number of solid tumor xenografts.
Specifications
Navicixizumab
Product Name Alternative
OMP-305B83, CAS: 1638338-43-8
Detection Method
Colorimetric
Assay Type
Quantitative
Sample Type
Plasma, Serum
Detection Range
0.31-5 μg/mL
Recovery
80-120%
Sensitivity
0.156 μg/ml
Shipping Conditions
2-8 °C
Storage Conditions
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Notes
For Research Use Only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740198-100 1x 100 µL
Cytokeratin 18 (DA7), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400923-500 1x 500 µL
Myosin, Smooth Muscle Heavy Chain (MYH11/923), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742340-100 1x 100 µL
Tyrosinase-Related Protein-1 (TYRP-1) (Melanoma Marker) (TYRP1/2340R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 